CHARLES F WAGNER JR Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES F WAGNER JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES F WAGNER JR. CHARLES F WAGNER JR is Chief Financial Officer in MILLIPORE CORP /MA ($MIL) and Vice President in MILLIPORE CORP /MA ($MIL) and Vice President, CFO in MILLIPORE CORP /MA ($MIL) and EVP & Chief Financial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP and CFO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP & Chief Financial Officer in BRUKER CORP ($BRKR).
CHARLES F WAGNER JR in VERTEX PHARMACEUTICALS INC / MA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES F WAGNER JR: EVP & Chief Financial Officer, EVP and CFO
Holdings: 34,679 shares
Current Value: $3,011,524
Latest Transaction: May 05 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHARLES F WAGNER JR in VERTEX PHARMACEUTICALS INC / MA
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BRKR, MIL, VRTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP & Chief Financi ... | Payment of Exercise | F | 217.21 | 547 | 118,814 | 34,679 | 35.2 K to 34.7 K (-1.55 %) |
| Jul 14 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP & Chief Financi ... | Sell | S | 293.90 | 260 | 76,414 | 16,126 | 16.4 K to 16.1 K (-1.59 %) |
| Jul 14 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP & Chief Financi ... | Sell | S | 292.86 | 400 | 117,144 | 16,386 | 16.8 K to 16.4 K (-2.38 %) |
| Jul 14 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP & Chief Financi ... | Sell | S | 291.19 | 40 | 11,648 | 16,786 | 16.8 K to 16.8 K (-0.24 %) |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Payment of Exercise | F | 251.78 | 547 | 137,724 | 16,727 | 17.3 K to 16.7 K (-3.17 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Payment of Exercise | F | 239.23 | 542 | 129,663 | 17,274 | 17.8 K to 17.3 K (-3.04 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Grant | A | 0.00 | 10,323 | 0 | 17,816 | 7.5 K to 17.8 K (+137.77 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Grant | A | 0.00 | 3,698 | 0 | 7,493 | 3.8 K to 7.5 K (+97.44 %) |
| Apr 12 2019 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Option Exercise | A | 189.38 | 9,532 | 1,805,170 | 9,532 | |
| Apr 12 2019 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Grant | A | 0.00 | 3,697 | 0 | 3,697 | 0 to 3.7 K |
Page: 1